Cargando…
Apetamin Hepatotoxicity: Potential Consequences of Purchasing a Body Enhancement Drug Off the Internet
We report Apetamin (cyproheptadine lysine and vitamin syrup), a non-US Food and Drug Administration-approved weight gain supplement, causing drug-induced autoimmune hepatitis. A 40-year-old previously healthy woman presented with fatigue, right-sided abdominal discomfort, and jaundice 6 weeks after...
Autores principales: | Garland, Victoria, Kumar, Anita, Theisen, Brian, Borum, Marie L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7535765/ https://www.ncbi.nlm.nih.gov/pubmed/33062775 http://dx.doi.org/10.14309/crj.0000000000000398 |
Ejemplares similares
-
Gastrointestinal and Hepatic Manifestations of COVID-19: Evolving Recognition and Need for Increased Understanding in Vulnerable Populations
por: Garland, Victoria, et al.
Publicado: (2021) -
Multiple drugs: Mild cholestasis, hepatotoxicity and off-label use: case report
Publicado: (2022) -
Hydroxychloroquine: Hepatotoxicity following off-label treatment: case report
Publicado: (2020) -
Prophylactic consequences of sodium salicylate nanoparticles in cisplatin-mediated hepatotoxicity
por: Alkhalaf, Maha, et al.
Publicado: (2023) -
Acute drug induced hepatitis secondary to a weight loss product purchased over the internet
por: Joshi, Deepak, et al.
Publicado: (2007)